Strategic Blueprint’s Opko Health OPK Stock Holding History

Strategic Blueprint’s Portfolio OPK Stock Details OPK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-500	Closed	-$2K	–	1030
2021 Q2	$2K	Buy	+500	New	+$1.96K	﹤0.01%	1240

Other funds holding OPK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Strategic Blueprint's OPK Position: Q3 2021 in Review

Strategic Blueprint sold out of Opko Health (OPK) in Q3 2021, closing a stake of 500 shares — an estimated $2K sold.

Strategic Blueprint first reported a position in OPK in Q2 2021 and held it in 1 quarter. The position peaked at $2K in Q2 2021. 206 funds tracked by Wall St. Rank hold OPK as of Q3 2021.

Strategic Blueprint reported no remaining Opko Health position as of Q3 2021 after selling out during the quarter.
Strategic Blueprint sold 500 Opko Health shares in Q3 2021, an estimated $2K.
Strategic Blueprint first reported a position in Opko Health in Q2 2021 and held it in 1 quarter.
Strategic Blueprint's Opko Health position peaked at $2K in Q2 2021.
206 funds tracked by Wall St. Rank held Opko Health as of Q3 2021.

Based on Strategic Blueprint's 13F filing for Q3 2021, filed 12 Nov 2021.